← Back to Search

Behavioral Intervention

Virtual Reality for ADHD

Phase 2
Waitlist Available
Led By Joshua M Langberg, PhD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must be between the ages of 18 and 25
Be between 18 and 65 years old
Must not have
Participants not meeting criteria for ADHD or not in the specified age range
Participants with a history of seizures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured immediately after the 6th and 11th vr intervention sessions and in the post-intervention surveys (taking place over a total of 1-1.5 months)
Awards & highlights

Summary

This trial is testing a virtual reality program to help young adults with ADHD focus better while doing homework and studying. Participants will use a virtual reality headset and some will also receive feedback on their focus levels.

Who is the study for?
This trial is for young adults aged 18-25 with ADHD. Participants should be currently enrolled in an educational program and have regular homework or study tasks. They must not have any conditions that would interfere with VR headset use, such as severe motion sickness or epilepsy.Check my eligibility
What is being tested?
The trial is testing a virtual reality program using the Meta Quest 3 VR Headset to improve focus during homework and studying for those with ADHD. It compares three groups: one using just the VR headset, another using the VR headset plus feedback on their focus levels, and a control group without these interventions.See study design
What are the potential side effects?
Potential side effects may include discomfort from wearing the VR headset, eye strain, headaches, dizziness or nausea due to motion sickness associated with virtual reality environments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 25 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have ADHD and I am outside the specified age range.
Select...
I have a history of seizures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured immediately after the 6th and 11th vr intervention sessions and in the post-intervention surveys (taking place over a total of 1-1.5 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured immediately after the 6th and 11th vr intervention sessions and in the post-intervention surveys (taking place over a total of 1-1.5 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Concentration
Productivity Rate
System usability and satisfaction
Secondary outcome measures
Effort
Motivation

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Virtual Reality + FeedbackExperimental Treatment1 Intervention
Participants in this condition wear the virtual reality headset. They are emersed in a virtual world that looks like a cabin room with windows. They are sitting at a desk and can see their laptop screen as part of the virtual world. The program tracks their keyboard and mouse click data to assess how consistently they are working. A stoplight in the virtual environment is green when they are working consistently and turns red when the not.
Group II: Virtual RealityExperimental Treatment1 Intervention
Participants in this condition wear the virtual reality headset. They are emersed in a virtual world that looks like a cabin room with windows. They are sitting at a desk and can see their laptop screen as part of the virtual world.
Group III: VR PassthroughActive Control1 Intervention
Participants in this condition wear the same VR headset as participants in the in the other arms. However, they see directly through to their laptop and are not emersed in the virtual world.

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
435 Previous Clinical Trials
64,978 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,820 Previous Clinical Trials
2,692,774 Total Patients Enrolled
95 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
20,045 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Louisiana State University Health Sciences Center in New OrleansOTHER
116 Previous Clinical Trials
44,063 Total Patients Enrolled
~30 spots leftby Apr 2025